Analysts polled by FactSet had estimated Abbott Laboratories' fourth-quarter sales to be $11.8 billion and earnings to be $1.50 a share. "Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes -- WSJ," at 10:22 a.m. ET on Jan. 22, incorrectly said analysts had estimated for sales of $12.78 billion and earnings of $1.63 a share.
(END) Dow Jones Newswires
January 23, 2026 11:59 ET (16:59 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.